TA174 Leukaemia (chronic lymphocytic, first line) - rituximab: understanding NICE guidance
|
TA174 Leukaemia (chronic lymphocytic, first line) - rituximab: understanding NICE guidance
22 July 2009 (58.51 Kb 17 sec) |
